Infliximab
Cat. No. :YN270613
CAS No. :170277-31-3
Product Name: | Infliximab |
CAS NO.: | 170277-31-3 |
Chemical Name: | |
Synonyms: | |
Molecular Weight: | 无Molecular Weight |
Molecular Formula: | 无Formula |
SMILES: | 无SMILES |
Storage: | Please store the product under the recommended conditions in the Certificate of Analysis. |
Transportation: | Room temperature in continental US; may vary elsewhere. |
Description: | Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds toTNF-α. Infliximab prevents the interaction ofTNF-αwith TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research. |
IC50&Target: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: | |
References: |
TELL : +86-020-82000279
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.